Healthcare & Life Sciences
KSQ Therapeutics
United Statesksqtx.com
KSQ Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 4 tracked investors.
activeseries-c-plus
series-c-plus
Stage
4
Investors
About KSQ Therapeutics
KSQ Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
KSQ Therapeutics develops CRISPR/Cas9-engineered tumor infiltrating lymphocyte therapies and leverages its CRISPRomics platform to discover therapeutic targets for the treatment of cancer.
Explore KSQ Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.